Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication - sprookjes - yvandenbroek - TriplyDB

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

http://www.wikidata.org/entity/Q27473218

about

Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A Hepatitis C virus proteins Chaperones in hepatitis C virus infection NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In Vitro Critical Role of Virion-Associated Cholesterol and Sphingolipid in Hepatitis C Virus Infection Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro Heat-shock Protein 90 Is Essential for Stabilization of the Hepatitis C Virus Nonstructural Protein NS3 Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication A Conserved Proline between Domains II and III of Hepatitis C Virus NS5A Influences both RNA Replication and Virus Assembly Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A The lipid droplet is an important organelle for hepatitis C virus production Cyclosporin A inhibits the influenza virus replication through cyclophilin A-dependent and -independent pathways Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening.A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Sphingomyelin activates hepatitis C virus RNA polymerase in a genotype-specific manner.Profile of alisporivir and its potential in the treatment of hepatitis C.Hepatitis C virus virology and new treatment targets.Domain 3 of NS5A protein from the hepatitis C virus has intrinsic alpha-helical propensity and is a substrate of cyclophilin A.Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infection The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action.Cyclosporin A inhibits the replication of diverse coronaviruses Cyclosporine as monotherapy for psoriasis in the setting of chronic HCV infection: a forgotten therapeutical option Hepatitis C virus utilizes VLDLR as a novel entry pathway.Cyclophilin inhibitors in hepatitis C viral infection.Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C post-liver transplantation increases sustained virologic response: a retrospective review.Investigational drugs for hepatitis C.Host-targeting agents in the treatment of hepatitis C: a beginning and an end?Cyclophilin inhibitors: a novel class of promising host-targeting anti-HCV agents.Exploitation of lipid components by viral and host proteins for hepatitis C virus infection.Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis.The adverse pharmacology of calcineurin inhibitors and their impact on hepatitis C recurrence after liver transplantation: implications for clinical practice.Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection

P2860

Q24303838-CDC77943-341C-4E37-8317-2E51DFAA0894 Q24563969-4E22CDBB-2A9F-4A2D-977E-09B6246B89A1 Q26771251-3834CD75-418A-4850-900C-08DD2AB07598 Q27477455-45EA4F20-9B39-4630-881E-B4601B8DA46B Q27480361-83A33F68-4592-4057-8A76-0E780A7DBDAE Q27486112-4E93657C-7036-408C-A75A-30F93A27C5B8 Q27486118-218BC1E6-F119-4E32-9716-417DF22A325F Q27488153-3EBC70CA-60AB-4204-B964-8DF93C4C8BBD Q27488216-FCD81FF9-47FC-40CC-9690-3541CD97F3EE Q27488369-5E0ED5A6-C937-409B-8E70-5B574432229D Q27488788-90732690-2CDA-46D2-ABFB-68356A00C9B2 Q27489053-670BCAFA-45DC-4481-984F-664CFDE5B460 Q27489795-7637BA57-1B86-4C21-859D-224DC8C6C665 Q27490200-D882373A-5403-455C-97EF-87EF399DA3B3 Q27491303-65CB3C4A-E58D-4D1F-A3DB-8A4994AEB711 Q28131709-1D15BF92-0E0C-431B-A013-E1B44F444E04 Q28483731-0FD7E027-E87F-4222-A213-587C904C5A18 Q28537660-50BBE5DF-1B60-433B-92CB-15A4199CFDB0 Q33303326-DD20ACB8-E98A-4762-BE53-2F5D65CDA2D0 Q33707739-550FE570-F513-43DD-A267-54C7A6095E44 Q34093754-55827975-1258-4B6E-A65B-94A81E75E20E Q34296036-37B7F77C-D299-4EDA-A011-5B62C4851565 Q34329744-24B2897B-1D06-486E-A7EF-59BAA135DA11 Q34974042-0C8C2E74-42EC-41B3-8F2F-92AEAD1CE8B8 Q35063336-D31B97CC-8283-4815-AAE9-478043B18ADB Q35731058-DE69BF66-DE08-4815-A7CA-36C276CE2B73 Q35742761-36D0F8BE-CAEA-46D2-96D7-3A6CBF77CA22 Q35960586-683AE883-ED22-4721-B8D9-0E169B1D3F41 Q36075071-30F80E15-E7C7-48DF-9868-BE1D694AE15B Q36459392-A5163DF5-B9F1-4AB8-A92D-75B35195F716 Q36916858-BAE246C9-26DC-4BA2-A5C4-254962652261 Q36993953-82A8F9BE-BC30-4025-956E-CA7F0DB951FB Q37222388-FD0A94A7-DBE3-46CA-B4E2-8E019ED7DDE6 Q37650377-1E76801F-3B27-4756-AE00-42C0CB7B3410 Q37676364-0DF7A5E2-A8BE-4617-B7EC-F3BF5D6AE52B Q37968485-EF15B091-5B57-43D9-8EB7-D0E894A1CCA3 Q37986051-94533B77-EAD3-4029-8D49-1FF86B30BFDC Q38028429-51E5351C-3A67-458A-9B71-A8A04311773D Q38057373-55BFF9FF-B990-4AE6-BCFF-202F065AA41B Q38064282-AC1BF224-46E1-4384-80F7-B6621CD7E32C

P2860

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

http://www.wikidata.org/entity/Q27473218

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@ast

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@en

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@nl

type

label

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@ast

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@en

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@nl

prefLabel

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@ast

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@en

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@nl

P1433

Q27473218-864ED69F-07BE-4119-9D80-EC888C55A71F

P1476

Q27473218-C43BEF17-8FE2-4000-8285-E58B234A15B0

P2093

Q27473218-0C239120-2BAC-4141-8206-6CCE6E05C4C5

Q27473218-158A2C16-0392-49F4-847F-C2EB172ADDF1

Q27473218-2E9D6B7D-086D-41D3-8988-D8E518B4D308

Q27473218-545396D0-4AC3-49E1-A71D-55508785A1B6

Q27473218-8124A9B0-6469-4524-A2A9-1D32ECD5802A

Q27473218-8614BAE9-3868-46AF-A320-74EB9BCAC59C

Q27473218-A6A98B0A-D30F-4643-980F-CFCB444FB37D

Q27473218-DAA89411-30C2-4C7D-B152-845E036AF1C2

P2860

Q27473218-0BFA9EC8-6A55-4678-9A9B-48E6643D2148

Q27473218-0F600B03-99A7-4907-BBCA-2C489A22C11A

Q27473218-132AA13D-5480-4B69-9911-E5FAA69D76A9

Q27473218-13A7BED6-7A30-4D7F-99E3-ADA8F0ED1772

Q27473218-2193C9CE-3C36-472F-A035-553EBB42F3C3

Q27473218-288C4FAA-2547-411A-BBA9-E2DB160F13CA

Q27473218-2C445352-20D9-4759-A51D-558104145BD0

Q27473218-2FA9E256-D8AE-4924-92D3-16B247BA5219

Q27473218-361AFA69-A79E-4024-B76E-6CD0B3BEAE41

Q27473218-42CCC255-BEC5-4066-8850-834304EFF037

P304

Q27473218-FB118B98-496B-4732-B7A2-ED2218A8FBAD

P31

Q27473218-4BCDB820-5495-4E88-A19D-65F8DF5C4AB5

P356

Q27473218-39D68ED9-0CF8-44A0-818E-4F8C2806602B

P433

Q27473218-44EBEE9E-A6BC-44CE-986C-E0330A55D00C

P478

Q27473218-F08CC43A-9EC5-45AD-AE39-AA8D48E7EA05

P50

Q27473218-3199B71B-1269-4C2D-9436-6338C0112BA1

P577

Q27473218-15CBCAED-4469-4694-86E7-10022D56EE94

P5875

Q27473218-41BC7A37-4039-47B3-A8EC-9BC258D02140

P698

Q27473218-E6F44BC3-DD51-4BDB-8613-151B636727B2

P921

Q27473218-107DE5CE-4B35-45E5-8C39-5A4675B7D8AC

P932

Q27473218-C3659E0F-1D3C-4A19-9B31-A78554C5BE7A

P356

JVI.80.9.4510-4520.2006

P1433

Journal of Virology

P1476

Diverse Effects of Cyclosporine on Hepatitis C Virus Strain Replication

@en

P2093

Daisuke Inoue

http://www.w3.org/2001/XMLSchema#string

Kaku Goto

http://www.w3.org/2001/XMLSchema#string

Koichi Watashi

http://www.w3.org/2001/XMLSchema#string

Kunitada Shimotohno

http://www.w3.org/2001/XMLSchema#string

Makoto Hijikata

http://www.w3.org/2001/XMLSchema#string

Naoto Ishii

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Kato

http://www.w3.org/2001/XMLSchema#string

Takayuki Hishiki

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase

Sequence analysis of the core gene of 14 hepatitis C virus genotypes

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus

Robust hepatitis C virus infection in vitro.

Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.

Expression and identification of hepatitis C virus polyprotein cleavage products

Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus

P304

4510-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.80.9.4510-4520.2006

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7168114

http://www.w3.org/2001/XMLSchema#string

P698

16611911

http://www.w3.org/2001/XMLSchema#string

P921

P932

1472040

http://www.w3.org/2001/XMLSchema#string